# NCT02945579 (NCT02945579)

> Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02945579
- Phase: NA
- Status: RECRUITING
- Sponsor: M.D. Anderson Cancer Center
- Conditions: Estrogen Receptor Negative; HER2 Positive Breast Carcinoma; HER2/Neu Negative; Invasive Breast Carcinoma; Progesterone Receptor Negative; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Triple-Negative Breast Carcinoma
- Interventions: Undergo EBRT; Laboratory Biomarker Analysis; Quality-of-Life Assessment; Questionnaire Administration; Partial Breast Irradiation
- Enrollment: 120
- Primary outcome: Ipsilateral breast tumor recurrence-free survival (IBT-RFS)
- Primary outcome: Overall survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 2
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct02945579